Zepp Health Corp

Zepp Health Corp(ZEPP)股票分析

$2.770

-0.142 (-5.14%)收盤時

Loading chart…
最高
2.940
開盤
2.860
成交量加權均價
2.65
成交量
161.24K
市值
35.99M
最低
2.230
成交金額
426.74K
企業價值/稅息折舊攤銷前利潤(TTM)
-2.39

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has one reportable segment: Amazfit-branded products.

AI 分析 of Zepp Health Corp (ZEPP)

賣出

Zepp Health Corp is not a good buy right now due to a current price of $3.02 and a concerning RSI of 5.838, indicating extreme oversold conditions. The company has reported a staggering year-to-date change of -89.23% and a one-year change of -93.94%, reflecting severe financial distress. Additionally, the forward P/E ratio stands at 3.124, which may seem low but is overshadowed by the company's ongoing net losses, including a net loss of $11.33 million in Q2 2026. The main risk is the widening operating loss and declining revenue expectations for Q3 2026, which could further impact stock performance.

估值指標

Zepp Health Corp(ZEPP)目前預期本益比為 3.12,5 年平均預期本益比為 -38.31。

預期本益比

合理
5 年均值 P/E
-38.31
目前P/E
3.12
高估
83.60
低估
-160.21

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-11.69
目前EV/EBITDA
-2.39
高估
22.14
低估
-45.52

預期股價營收比

合理
5 年均值 P/S
0.37
目前P/S
0.02
高估
0.96
低估
-0.22

持有 ZEPP 的大戶

T

Trivest Advisors Ltd

+ 持有ZEPP

-14.92%

3個月報酬率

事件時間軸

2026-09-22 (ET)

07:30:00

Amazfit Launches T-Rex Dual Solar Smartwatch at $649.99

2026-06-08 (ET)

21:40:00

Q1 Revenue Reaches $51.5 Million

2026-05-13 (ET)

07:30:00

Amazfit Launches Cheetah 2 Ultra at $599.99

2026-04-16 (ET)

07:10:00

Amazfit Launches Cheetah 2 Pro Sports Watch at $449.99

2026-04-15 (ET)

07:10:00

Zepp Health Signs Three-Year Global Partnership with HYROX

資訊

ZEPP 常見問題 —— 由 Alphio AI 解答

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has one reportable segment: Amazfit-branded products. It operates in the Technology sector (ELECTRONIC COMPUTERS industry).

Zepp Health Corp is not a good buy right now due to a current price of $3.02 and a concerning RSI of 5.838, indicating extreme oversold conditions. The company has reported a staggering year-to-date change of -89.23% and a one-year change of -93.94%, reflecting severe financial distress. Additionally, the forward P/E ratio stands at 3.124, which may seem low but is overshadowed by the company's ongoing net losses, including a net loss of $11.33 million in Q2 2026. The main risk is the widening operating loss and declining revenue expectations for Q3 2026, which could further impact stock performance.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易